Durham, NC (PRWEB) July 12, 2013 A new protocol for reprogramming induced pluripotent stem cells (iPSCs) into mature blood cells, using just a small amount of the patients own blood and a readily available cell type, is reported on in the current issue of STEM CELLS Translational Medicine. This novel method skips the generally accepted process of mixing iPSCs with either mouse or human stromal cells during the differentiation process and, in essence, ensures no outside and potentially harmful DNA is introduced into the reprogrammed cells. As such, it could lead to a purer, safer therapeutic grade of stem cells for use in regenerative medicine. The discovery of iPSCs holds great promise for regenerative medicine since it is possible to produce patient-specific iPSCs from the individual for potential autologous treatment that is, treatment using the patients own cells. This avoids the possibility of rejection and numerous other harmful side effects. CD34+ cells are a type of blood stem cell that has been linked to proliferation. However, collecting enough CD34+ cells from a patient to produce an adequate amount of blood usually requires a large volume of blood to be taken from the patient. But scientists found a way around this, … Continue reading →

NEW YORK, NY, July 12, 2013 - (eTeligis via ACCESSWIRE) IntelliCell BioSciences, Inc. (OTC PINK: SVFC), a developer of novel, patented stromal vascular fraction cells (stem cells) technologies that address the regenerative, curative and preventative conditions of disease states, announces an online interview where they discuss their current SVF (stem cell) treatment technology. Dr. Steven Victor, the Chairman and CEO of IntelliCell BioSciences, Inc. conducted an online interview where he discusses the company's current SVF (stem cell) treatment technology, and prospects for their patented extraction technology in healthcare facilities in the US. To access the online interview please visit http://www.wallstreetnewscast.com/profile/svfc.html Register for Mailing List If you would like to be added to SVFC mailing list, receive updates, or submit a question to the company, please register online at http://www.wallstreetnewscast.com/request/svfc.html About IntelliCell BioSciences IntelliCell BioSciences is a Regenerative Medicine company developing novel technologies that address the regenerative, curative and preventative conditions of disease states with high unmet clinical needs. The Company has patented technology for the use of ultrasonic cavitation for separating stromal vascular fraction with stem cells from adipose tissue and several patent-pending. The Company is also pioneering the development of autologous and allogeneic cells from living and non-living tissue … Continue reading →

Activity Theory and Interface Design for Autism Treatment The purpose of this exploration is to research activity theory and its implications on user experience and interface design, particularly in a classroom envi... By: CourtneyLMar … Continue reading →

Washington, July 12 (ANI): A new research has found a full genome sequencing examining the entire DNA code of individuals with autism spectrum disorder (ASD) and their family members - a finding that could provide a definitive look at the wide ranging genetic variations associated with ASD. The study reports on full genome sequencing on 32 unrelated Canadian individuals with autism and their families, participants in the Autism Speaks Autism Genetic Resource Exchange (AGRE). The results include both inherited as well as spontaneous or de novo, genetic alterations found in one half of the affected families sequenced. This dramatic finding of genetic risk variants associated with clinical manifestation of ASD or accompanying symptoms in 50 percent of the participants tested is promising, as current diagnostic technology has only been able to determine a genetic basis in about 20 percent of individuals with ASD tested. The large proportion of families identified with genetic alterations of concern is in part due to the comprehensive and uniform ability to examine regions of the genome possible with whole genome sequencing missed in other lower resolution genome scanning approaches. "From diagnosis to treatment to prevention, whole genome sequencing efforts like these hold the potential to … Continue reading →

11 July 2013 Media Release July 2013 Autism New Zealand is excited to bring Stephen Shore to New Zealand Autism New Zealand is proud to be hosting Stephen Shore in New Zealand where he will give a series of seminars in Auckland, Wellington and Christchurch. Stephen Shores seminar theme is Success with Autism: Using our Strengths for Achieving a Fulfilling and Productive Life Just like Everyone Else. Diagnosed with Atypical development and strong autistic tendencies and too sick for outpatient treatment Stephen Shore was recommended for institutionalisation. Nonverbal until four, and with much support from his parents, teachers, wife, and others, Stephen is now a professor at Adelphi University where his research focuses on matching best practice to meet the needs of people with autism. Stephen Shore is President emeritus of the Aspergers Association of New England and former board member of the Autism Society. Stephen Shore serves in the Interagency Autism Coordinating Committee, Asperger Syndrome and High Functioning Autism Association, United States Autism and Asperger Alliance and other autism related organisations. This will be Stephens only New Zealand seminar tour. Seminars are from 9.00am 1.00pm Auckland 31 July, Wellington 2 August and Christchurch 5 August. ends Follow this link: … Continue reading →

Autism New Zealand is proud to be hosting Stephen Shore in New Zealand where he will give a series of seminars in Auckland, Wellington and Christchurch. Stephen Shores seminar theme is Success with Autism: Using our Strengths for Achieving a Fulfilling and Productive Life - Just like Everyone Else". Diagnosed with "Atypical development and strong autistic tendencies" and "too sick" for outpatient treatment Stephen Shore was recommended for institutionalisation. Nonverbal until four, and with much support from his parents, teachers, wife, and others, Stephen is now a professor at Adelphi University where his research focuses on matching best practice to meet the needs of people with autism. Stephen Shore is President emeritus of the Aspergers Association of New England and former board member of the Autism Society. Stephen Shore serves in the Interagency Autism Coordinating Committee, Asperger Syndrome and High Functioning Autism Association, United States Autism and Asperger Alliance and other autism related organisations. This will be Stephens only New Zealand seminar tour. Seminars are from 9.00am - 1.00pm Auckland 31 July, Wellington 2 August and Christchurch 5 August. Read more here: Autism NZ is excited to bring Stephen Shore to NZ … Continue reading →

Newswise A Vanderbilt research program that trains community pediatricians to diagnose autism within their individual practices may lead to more effective treatment of the disorder that now affects an estimated one in 88 children. Vanderbilt University Medical Center researchers released today in the journal Autism the results of a three-year study that evaluated the effectiveness of a training program designed to enhance autism spectrum disorder (ASD) identification and assessment within community pediatric settings across Tennessee. After participating in training to learn strategies for conducting rapid diagnostic assessments following positive ASD screenings, pediatricians reported significant changes in their screening and consultation practices, with 85 percent reporting an increase in numbers of children with autism evaluated within their practice. The study also found that pediatric providers were nearly as accurate as specialists in their diagnoses, with agreement seen in more than 90 percent of all cases. Ideally, definitive early diagnosis of ASD would be rapidly accomplished by a team of developmental specialists, and children at risk for diagnosis would obtain services immediately after screening positive. The reality is that such diagnostic teams, or even individual professionals, are not available in most locations, said corresponding author Zachary Warren, Ph.D., associate professor of Pediatrics, … Continue reading →

Public release date: 11-Jul-2013 [ | E-mail | Share ] Contact: Jane E. Rubinstein jrubinstein@rubenstein.com 212-843-8287 Autism Speaks NEW YORK, N.Y. -- A collaborative formed by Autism Speaks, the world's leading autism science and advocacy organization, has found full genome sequencing examining the entire DNA code of individuals with autism spectrum disorder (ASD) and their family members to provide the definitive look at the wide ranging genetic variations associated with ASD. The study published online today in American Journal of Human Genetics, reports on full genome sequencing on 32 unrelated Canadian individuals with autism and their families, participants in the Autism Speaks Autism Genetic Resource Exchange (AGRE). The results include both inherited as well as spontaneous or de novo, genetic alterations found in one half of the affected families sequenced. This dramatic finding of genetic risk variants associated with clinical manifestation of ASD or accompanying symptoms in 50 percent of the participants tested is promising, as current diagnostic technology has only been able to determine a genetic basis in about 20 percent of individuals with ASD tested. The large proportion of families identified with genetic alterations of concern is in part due to the comprehensive and uniform ability to examine … Continue reading →

July 11, 2013 A collaborative formed by Autism Speaks, the world's leading autism science and advocacy organization, has found full genome sequencing examining the entire DNA code of individuals with autism spectrum disorder (ASD) and their family members to provide the definitive look at the wide ranging genetic variations associated with ASD. The study published online today in American Journal of Human Genetics, reports on full genome sequencing on 32 unrelated Canadian individuals with autism and their families, participants in the Autism Speaks Autism Genetic Resource Exchange (AGRE). The results include both inherited as well as spontaneous or de novo, genetic alterations found in one half of the affected families sequenced. This dramatic finding of genetic risk variants associated with clinical manifestation of ASD or accompanying symptoms in 50 percent of the participants tested is promising, as current diagnostic technology has only been able to determine a genetic basis in about 20 percent of individuals with ASD tested. The large proportion of families identified with genetic alterations of concern is in part due to the comprehensive and uniform ability to examine regions of the genome possible with whole genome sequencing missed in other lower resolution genome scanning approaches. "From diagnosis … Continue reading →

Cong Ty QNet Viet Nam Testimonial Bio Disc Stroke Treatment Testimony IR ID No HG707037 Contact: Ngo Anh Vu (Mr Vince) - 0932571102 http://www.qnetestore.com http://www.qnetvietnam.info http://www.youtube.com/kinhdoanhcungqnet http://www.qnet.ne... By: kinhdoanhcungqnet … Continue reading →